Barrier Methods for Human Immunodeficiency Virus Prevention - 21/11/14
, Craig J. Hoesley, MDRésumé |
Condoms remain the most effective barrier against the sexual transmission of the human immunodeficiency virus (HIV). Male condoms have proven to be 80% to 90% effective, and female condoms have similar results. Poor adherence and improper use limit their effectiveness. In addition to condoms, microbicides are a promising barrier against HIV transmission. More than 50 candidate topical microbicide compounds have undergone preclinical or clinical testing in the last 10 years, but there are currently no US Food and Drug Administration (FDA)-approved compounds. Rectal microbicides are also being developed, as anal receptive sex is an effective mode of HIV transmission.
Le texte complet de cet article est disponible en PDF.Keywords : Human immunodeficiency virus prevention, Male condoms, Female condoms, Microbicides
Plan
| Disclosure: The authors whose names are listed immediately above certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements) or nonfinancial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this article. |
Vol 28 - N° 4
P. 585-599 - décembre 2014 Retour au numéro
Article précédent
- Pre-exposure Prophylaxis for Human Immunodeficiency Virus : The Past, Present, and Future
- Amanda D. Castel, Manya Magnus, Alan E. Greenberg
- Prevention of Human Immunodeficiency Virus and AIDS : Postexposure Prophylaxis (Including Health Care Workers)
- Susan E. Beekmann, David K. Henderson
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?